ESCROW AGREEMENTEscrow Agreement • September 29th, 2022 • Kurve Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This ESCROW AGREEMENT (this “Agreement”) dated as of this 10th day of May 2022 by and among Kurve Therapeutics, Inc, a Delaware corporation (the “Company”), having an address at 16825 48th W, Suite 434, Lynwood, WA 98037; Rialto Markets, LLC, having an address at 42 Broadway, Ste 12-129, NY, NY 10004 (“Placement Agent”), and WILMINGTON TRUST, NATIONAL ASSOCIATION (the “Escrow Agent”), with its principal corporate trust office at 99 Wood Avenue South, 10th Floor, Iselin, NJ 08830. The Company and the Placement Agent, each a “Party,” are collectively referred to as “Parties” and individually, a “Party.”
KURVE THERAPEUTICS, INC., A DELAWARE CORPORATION COMMON STOCK SHARES REGULATION A+ SUBSCRIPTION AGREEMENTRegulation A+ Subscription Agreement • September 29th, 2022 • Kurve Therapeutics, Inc. • Pharmaceutical preparations
Investing in securities represented by shares of common stock (“Shares”) of Kurve Therapeutics, Inc. (the “Company”) involves significant risks. This investment is suitable only for persons who can afford to lose their entire investment and such investment could be illiquid for an indefinite period of time. No public market currently exists for the Shares, and if a public market develops following this offering, it may not continue.
